IMGN logo

ImmunoGen (IMGN) Accounts Payable

Annual Accounts Payable

$45.35 M
+$26.92 M+146.03%

December 31, 2022

Summary

Performance

1-Year Change

+146.03%

3-Year Change

+356.59%

5-Year Change

+429.7%

15-Year Change

+429.7%

IMGN Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$45.35 M
IMGN annual accounts payable is currently at an all-time high

3-Year Low

$18.43 M
IMGN annual accounts payable is currently +146.03% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
IMGN previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
IMGN next annual earnings announcement has not yet been scheduled

OtherIMGNbalance sheetmetrics:

Annual Accounts Receivable

$12.60 M
IMGN annual accounts receivable is $12.60 million

Annual Total Liabilities

$193.11 M
IMGN annual total liabilities is $193.11 million

Annual Total Assets

$348.94 M
IMGN annual total assets is $348.94 million

Annual Current Assets

$304.12 M
IMGN annual total current assets is $304.12 million

Quarterly Accounts Payable

$24.85 M
+$6.41 M+34.77%

September 30, 2023

Summary

Performance

3-Month Change

+34.77%

1-Year Change

+23.17%

3-Year Change

+178.84%

5-Year Change

+140.08%

IMGN Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$45.35 M
IMGN quarterly accounts payable is currently -45.20% below its historical high of $45.35 million

3-Year Low

$16.06 M
IMGN quarterly accounts payable is currently +54.75% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
IMGN previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
IMGN next earnings announcement has not yet been scheduled

OtherIMGNbalance sheetmetrics:

Quarterly Accounts Receivable

$130.69 M
IMGN quarterly accounts receivable is $130.69 million

Quarterly Total Liabilities

$260.50 M
IMGN quarterly total liabilities is $260.50 million

Quarterly Total Assets

$822.10 M
IMGN quarterly total assets is $822.10 million

Quarterly Current Assets

$766.90 M
IMGN quarterly total current assets is $766.90 million

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

IMGN Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+146.0%+23.2%
3 y3 years+356.6%+178.8%
5 y5 years+429.7%+140.1%

IMGN Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-59.4%-45.2%-35.4%
5 y5-yearat high-79.0%-45.2%-64.1%
alltimeall timeat high-99.7%-45.2%-99.4%

ImmunoGen Accounts Payable History

DateAnnualQuarterly
Sep 2023
-
$24.85 M(+34.8%)
Jun 2023
-
$18.44 M(-42.8%)
Mar 2023
-
$32.26 M(-28.9%)
Dec 2022
$45.35 M(+146.0%)
$45.35 M(+124.8%)
Sep 2022
-
$20.18 M(+17.0%)
Jun 2022
-
$17.25 M(+7.4%)
Mar 2022
-
$16.06 M(-12.9%)
Dec 2021
$18.43 M(+93.3%)
$18.43 M(+75.2%)
Sep 2021
-
$10.52 M(-9.6%)
Jun 2021
-
$11.63 M(-9.9%)
Mar 2021
-
$12.92 M(+35.4%)
Dec 2020
$9.54 M(-4.0%)
$9.54 M(+7.0%)
Sep 2020
-
$8.91 M(-30.0%)
Jun 2020
-
$12.74 M(+33.6%)
Mar 2020
-
$9.53 M(-4.0%)
Dec 2019
$9.93 M(-12.6%)
$9.93 M(+37.4%)
Sep 2019
-
$7.23 M(-7.5%)
Jun 2019
-
$7.81 M(-11.0%)
Mar 2019
-
$8.78 M(-22.8%)
Dec 2018
$11.37 M(+32.7%)
$11.37 M(+9.8%)
Sep 2018
-
$10.35 M(-19.6%)
Jun 2018
-
$12.88 M(+65.4%)
Mar 2018
-
$7.79 M(-9.1%)
Dec 2017
$8.56 M(+8.4%)
$8.56 M(+29.5%)
Sep 2017
-
$6.61 M(+28.4%)
Jun 2017
-
$5.15 M(+1.0%)
Mar 2017
-
$5.10 M(-43.2%)
Dec 2016
$7.89 M(-31.4%)
-
Sep 2016
-
$8.97 M(-22.0%)
Jun 2016
$11.51 M(+41.4%)
$11.51 M(+14.0%)
Mar 2016
-
$10.10 M(-24.6%)
Dec 2015
-
$13.40 M(+38.3%)
Sep 2015
-
$9.69 M(+19.1%)
Jun 2015
$8.14 M(+68.9%)
$8.14 M(+28.7%)
Mar 2015
-
$6.32 M(+12.6%)
Dec 2014
-
$5.61 M(+13.2%)
Sep 2014
-
$4.96 M(+2.9%)
Jun 2014
$4.82 M(+7.1%)
$4.82 M(+1.6%)
Mar 2014
-
$4.74 M(+24.4%)
Dec 2013
-
$3.81 M(+22.1%)
Sep 2013
-
$3.12 M(-30.6%)
Jun 2013
$4.50 M(+32.5%)
$4.50 M(+65.2%)
Mar 2013
-
$2.72 M(-42.1%)
Dec 2012
-
$4.71 M(+46.3%)
Sep 2012
-
$3.22 M(-5.3%)
Jun 2012
$3.40 M(+5.7%)
$3.40 M(+28.8%)
Mar 2012
-
$2.63 M(+77.6%)
Dec 2011
-
$1.48 M(-47.9%)
Sep 2011
-
$2.85 M(-11.3%)
Jun 2011
$3.21 M(+4.9%)
$3.21 M(+25.1%)
Mar 2011
-
$2.57 M(+45.2%)
Dec 2010
-
$1.77 M(+62.0%)
Sep 2010
-
$1.09 M(-64.4%)
Jun 2010
$3.06 M(+146.3%)
$3.06 M(+139.4%)
Mar 2010
-
$1.28 M(-35.4%)
Dec 2009
-
$1.98 M(+88.5%)
Sep 2009
-
$1.05 M(-15.5%)
Jun 2009
$1.24 M(-11.8%)
$1.24 M(-49.7%)
Mar 2009
-
$2.47 M(+2.9%)
Dec 2008
-
$2.40 M(+39.7%)
Sep 2008
-
$1.72 M(+21.9%)
Jun 2008
$1.41 M(-36.6%)
$1.41 M(-85.2%)
Mar 2008
-
$9.50 M(+338.3%)
Dec 2007
-
$2.17 M(+14.6%)
Sep 2007
-
$1.89 M(-15.0%)
Jun 2007
$2.23 M
$2.23 M(+1.1%)
Mar 2007
-
$2.20 M(+101.5%)
DateAnnualQuarterly
Dec 2006
-
$1.09 M(-41.5%)
Sep 2006
-
$1.87 M(+38.9%)
Jun 2006
$1.35 M(-35.9%)
$1.35 M(-8.9%)
Mar 2006
-
$1.48 M(+57.1%)
Dec 2005
-
$940.00 K(-30.5%)
Sep 2005
-
$1.35 M(-35.6%)
Jun 2005
$2.10 M(-2.2%)
$2.10 M(-36.0%)
Mar 2005
-
$3.28 M(+95.9%)
Dec 2004
-
$1.67 M(+4.7%)
Sep 2004
-
$1.60 M(-25.5%)
Jun 2004
$2.15 M(+1340.3%)
$2.15 M(-13.3%)
Mar 2004
-
$2.47 M(+100.9%)
Dec 2003
-
$1.23 M(-4.0%)
Sep 2003
-
$1.28 M(+760.7%)
Jun 2003
$149.00 K(-74.4%)
$149.00 K(-94.5%)
Mar 2003
-
$2.73 M(+178.2%)
Dec 2002
-
$979.60 K(+70.8%)
Sep 2002
-
$573.40 K(-1.3%)
Jun 2002
$581.00 K(-31.1%)
$581.00 K(-73.4%)
Mar 2002
-
$2.18 M(+49.4%)
Dec 2001
-
$1.46 M(+69.8%)
Sep 2001
-
$860.30 K(+2.1%)
Jun 2001
$842.90 K(-5.4%)
$842.90 K(-9.5%)
Mar 2001
-
$930.90 K(+49.9%)
Dec 2000
-
$620.90 K(-35.5%)
Sep 2000
-
$961.90 K(+7.9%)
Jun 2000
$891.40 K(-1.0%)
$891.40 K(+6.2%)
Mar 2000
-
$839.20 K(+4.9%)
Dec 1999
-
$800.00 K(-11.1%)
Sep 1999
-
$900.00 K(0.0%)
Jun 1999
$900.00 K(+28.6%)
$900.00 K(+28.6%)
Mar 1999
-
$700.00 K(0.0%)
Dec 1998
-
$700.00 K(+16.7%)
Sep 1998
-
$600.00 K(-14.3%)
Jun 1998
$700.00 K(+16.7%)
$700.00 K(+16.7%)
Mar 1998
-
$600.00 K(-25.0%)
Dec 1997
-
$800.00 K(+33.3%)
Sep 1997
-
$600.00 K(0.0%)
Jun 1997
$600.00 K(-14.3%)
$600.00 K(-14.3%)
Mar 1997
-
$700.00 K(-30.0%)
Dec 1996
-
$1.00 M(-9.1%)
Sep 1996
-
$1.10 M(+57.1%)
Jun 1996
$700.00 K(-68.2%)
$700.00 K(-70.8%)
Mar 1996
-
$2.40 M(+20.0%)
Dec 1995
-
$2.00 M(-9.1%)
Sep 1995
-
$2.20 M(0.0%)
Jun 1995
$2.20 M(0.0%)
$2.20 M(+4.8%)
Mar 1995
-
$2.10 M(+31.3%)
Sep 1994
-
$1.60 M(-27.3%)
Jun 1994
$2.20 M(-15.4%)
$2.20 M(-26.7%)
Mar 1994
-
$3.00 M(+36.4%)
Dec 1993
-
$2.20 M(+57.1%)
Sep 1993
-
$1.40 M(-46.2%)
Jun 1993
$2.60 M(+73.3%)
$2.60 M(+62.5%)
Mar 1993
-
$1.60 M(+14.3%)
Dec 1992
-
$1.40 M(+16.7%)
Sep 1992
-
$1.20 M(-20.0%)
Jun 1992
$1.50 M(+15.4%)
$1.50 M(+36.4%)
Mar 1992
-
$1.10 M(+10.0%)
Sep 1991
-
$1.00 M(-23.1%)
Jun 1991
$1.30 M(-18.8%)
$1.30 M(-27.8%)
Mar 1991
-
$1.80 M(+20.0%)
Dec 1990
-
$1.50 M(-6.3%)
Sep 1990
-
$1.60 M(0.0%)
Jun 1990
$1.60 M(+45.5%)
$1.60 M(+6.7%)
Mar 1990
-
$1.50 M(+15.4%)
Sep 1989
-
$1.30 M(+18.2%)
Jun 1989
$1.10 M
$1.10 M

FAQ

  • What is ImmunoGen annual accounts payable?
  • What is the all time high annual accounts payable for ImmunoGen?
  • What is ImmunoGen annual accounts payable year-on-year change?
  • What is ImmunoGen quarterly accounts payable?
  • What is the all time high quarterly accounts payable for ImmunoGen?
  • What is ImmunoGen quarterly accounts payable year-on-year change?

What is ImmunoGen annual accounts payable?

The current annual accounts payable of IMGN is $45.35 M

What is the all time high annual accounts payable for ImmunoGen?

ImmunoGen all-time high annual accounts payable is $45.35 M

What is ImmunoGen annual accounts payable year-on-year change?

Over the past year, IMGN annual accounts payable has changed by +$26.92 M (+146.03%)

What is ImmunoGen quarterly accounts payable?

The current quarterly accounts payable of IMGN is $24.85 M

What is the all time high quarterly accounts payable for ImmunoGen?

ImmunoGen all-time high quarterly accounts payable is $45.35 M

What is ImmunoGen quarterly accounts payable year-on-year change?

Over the past year, IMGN quarterly accounts payable has changed by +$4.67 M (+23.17%)